Nuvalent Quote - NUVL

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

83.80

Bid

83.00

Ask

88.45

Volume

942

0.00 Day's Range 0.00

61.795 52 Week Range 113.51

Market Cap

5.954B

Previous Close

84.64

Open

Last Trade

100

83.8

(formt)

Last Trade Time

07:27:30

Financial Volume

VWAP

Average Volume (3m)

420,890

Shares Outstanding

71,052,559

Dividend Yield

PE Ratio

-47.65

Earnings Per Share (EPS)

-1.78

Revenue

Net Profit

-126.22M

Nuvalent Inc is a biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer, designed to overcome the limitations of existing therapies for clinically proven kinase targets. Nuvalent Inc is a biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer, designed to overcome the limitations of existing therapies for clinically proven kinase targets.

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.nuvalent.com

Headquarters

Wilmington, Delaware, USA

Founded

Nuvalent Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker NUVL. The last closing price for Nuvalent was US$84.64. Over the last year, Nuvalent shares have traded in a share price range of US$ 61.795 to US$ 113.51.

Nuvalent currently has 71,052,559 shares outstanding. The market capitalization of Nuvalent is US$6.01 billion. Nuvalent has a price to earnings ratio (PE ratio) of -47.65.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-2.19	-2.54680776835	85.99	89.305	80.96	593169	86.16411818	CS
4	-8.6815	-9.38728286198	92.4815	97.65	80.96	393516	90.36365702	CS
12	-17.96	-17.6493710692	101.76	106.32	80.96	420890	93.74783469	CS
26	5.9	7.57381258023	77.9	113.51	64.67	440408	90.81698534	CS
52	9.73	13.1362224922	74.07	113.51	61.795	434380	82.92467086	CS
156	61.59	277.307519136	22.21	113.51	7.09	351406	56.81440951	CS
260	65.7	362.983425414	18.1	113.51	7.09	329339	55.14988087	CS

NUVL - Frequently Asked Questions (FAQ)

What is the current Nuvalent share price?

The current share price of Nuvalent is US$ 83.80

How many Nuvalent shares are in issue?

Nuvalent has 71,052,559 shares in issue

What is the market cap of Nuvalent?

The market capitalisation of Nuvalent is USD 6.01B

What is the 1 year trading range for Nuvalent share price?

Nuvalent has traded in the range of US$ 61.795 to US$ 113.51 during the past year

What is the PE ratio of Nuvalent?

The price to earnings ratio of Nuvalent is -47.65

What is the reporting currency for Nuvalent?

Nuvalent reports financial results in USD

What is the latest annual profit for Nuvalent?

The latest annual profit of Nuvalent is USD -126.22M

What is the registered address of Nuvalent?

The registered address for Nuvalent is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801

What is the Nuvalent website address?

The website address for Nuvalent is www.nuvalent.com

Which industry sector does Nuvalent operate in?

Nuvalent operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MYSZMy Size Inc	US$ 6.15 (355.56%)	41.48M
LYTLytus Technologies Holdings PTV Ltd	US$ 2.85 (183.58%)	20.13M
HSDTHelius Medical Technologies Inc	US$ 1.03 (114.58%)	48.8M
TAOPTaoping Inc BVI	US$ 0.56 (76.66%)	47.29M
HUMAHumacyte Inc	US$ 5.9399 (71.67%)	14.42M
CYNCYNGN Inc	US$ 0.75 (-53.42%)	606.72k
MTEMMolecular Templates Inc	US$ 0.178 (-49.14%)	940.77k
PRFXPainReform Ltd	US$ 7.12 (-36.20%)	438.96k
GALTGalectin Therapeutics Inc	US$ 1.28 (-36.00%)	1.29M
HYZNHyzon Motors Inc	US$ 1.0902 (-34.33%)	79.05k
HSDTHelius Medical Technologies Inc	US$ 1.0401 (116.69%)	48.81M
TAOPTaoping Inc BVI	US$ 0.5517 (74.04%)	47.29M
APTOAptose Biosciences Inc	US$ 0.28 (64.51%)	42.77M
MYSZMy Size Inc	US$ 6.23 (361.48%)	41.53M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.578 (1.40%)	26.96M